GNRH1 and ovarian hyperstimulation syndrome: The GnRH antagonist protocol can reduce the incidence of severe OHSS compared to the follicular phase GnRH agonist protocol; thus, it has been regarded as a first-line COS protocol for PCOS patients (13).